    Sentence 1: About 18 percent of men  taking finasteride developed prostate  cancer , compared with 24 percent on  placebo .    Sentence 2: They found that 6.4 percent  of men on finasteride had high-grade  tumors , compared to 5.1 percent taking  a placebo .